Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
Search results for: melanoma
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
Rheumatologists On The Move
Awards, appointments, and announcements in the world of rheumatology
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome
SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians
How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases
Studying the relationships between microbes and their hosts, the role for Bacille Calmette Guerin (BCG) as a vaccine for Type I diabetes, and emotional stress and bone metastases
Drug Updates
Information on new approvals and medication safety
Are We Playing It Safe?
Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Another Vocabulary for Rheumatology Research
Matt Liang, MD, MPH, addresses patients’ authentic concerns
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- Next Page »